Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Influence of ritonavir on olanzapine pharmacokinetics in healthy volunteers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Pharmacokinetics
100%
Healthy Volunteers
100%
Olanzapine
100%
Ritonavir
100%
Twice Daily
27%
Blood Samples
18%
Plasma Samples
9%
Area under the Concentration-time Curve
9%
Oral Clearance
9%
Peak Concentration
9%
Cytochrome P450 1A2 (CYP1A2)
9%
Student's T-test
9%
Systemic Exposure
9%
HIV Infection
9%
Therapeutic Effect
9%
Pharmacokinetic Parameters
9%
Atypical Antipsychotics
9%
HIV Protease Inhibitors
9%
Parameter Values
9%
Noncompartmental
9%
Glucuronosyltransferase
9%
Psychotic Illness
9%
Pharmacology, Toxicology and Pharmaceutical Science
Normal Human
100%
Olanzapine
100%
Ritonavir
100%
Pharmacokinetics
100%
Disease
9%
CYP1A2
9%
Human Immunodeficiency Virus Infection
9%
High Performance Liquid Chromatography
9%
Pharmacokinetic Parameter
9%
Atypical Antipsychotics
9%
Human Immunodeficiency Virus Proteinase Inhibitor
9%
Therapeutic Effect
9%
Glucuronosyltransferase
9%